Elsevier Health expands access to ClinicalKey AI to individual medical residents and physicians

Elsevier Health 新しいタブ／ウィンドウで開く, a global leader in medical information and data analytics, today announced the expansion of ClinicalKey AI to individual medical residents and physicians across the US to better support clinical decision-making at the point of care.

Access to trusted, evidence-based medical information is of the utmost importance to time-pressed physicians. ClinicalKey AI, now available to individual residents and physicians through a monthly or annual subscription, addresses this challenge by leveraging a sophisticated conversational search interface to deliver accurate, succinct clinical information. The solution has been designed to provide high-quality curated content and constantly refreshed evidence-based research to help physicians make clinical decisions and improve the patient experience.

The expansion of ClinicalKey AI is based on valuable feedback from physicians who are keen to utilize AI tools in a responsible manner. In Elsevier’s 2024 Insights Toward AI Report, which includes the latest insights from nearly 3,000 researchers and clinicians, 96% of clinicians believe AI will help accelerate knowledge discovery and 88% believe AI will help increase work quality overall.

Louise Chang, MD, Global VP, Digital Content Strategy and Partnerships, Elsevier Health said: "Physicians continue to face challenges with resource constraints, time pressure and data overload and we aim to address these challenges by simplifying their access to relevant, evidence-based information through an AI tool they can trust. ClinicalKey AI is a fast and easy clinical support tool that brings together best-in class content with technology enabling a new level of accessibility to information and insights.”

For more than two decades, Elsevier has been using AI and machine learning technologies in combination with our world-class peer-reviewed content and extensive data sets to create solutions that help the research, life sciences and healthcare communities be more effective every day

To learn more about ClinicalKey AI, please click here 新しいタブ／ウィンドウで開く.

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。